Cargando…

Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214

SIMPLE SUMMARY: To investigate a possible treatment strategy for hormone receptor (HR)-positive, HER2-negative advanced and/or metastatic breast cancer (AMBC), we investigated the clinical usefulness of adding capecitabine to maintenance endocrine therapy after induction chemotherapy and the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Norikazu, Yoshinami, Tetsuhiro, Ikeda, Masahiko, Mizutani, Makiko, Yamaguchi, Miki, Komoike, Yoshifumi, Takashima, Tsutomu, Yoshidome, Katsuhide, Tsurutani, Junji, Iwamoto, Mitsuhiko, Fujisawa, Fumie, Yasojima, Hiroyuki, Yamamura, Jun, Morishima, Hirotaka, Aki, Fuminori, Yamada, Tomomi, Morita, Satoshi, Nakayama, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430728/ https://www.ncbi.nlm.nih.gov/pubmed/34503209 http://dx.doi.org/10.3390/cancers13174399

Ejemplares similares

Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917)
por: Nakayama, Takahiro, et al.
Publicado: (2021)

Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)
por: Futamura, Manabu, et al.
Publicado: (2023)

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
por: Iwasa, Tsutomu, et al.
Publicado: (2019)

Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
por: Hattori, Masaya, et al.
Publicado: (2017)

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
por: Ohtani, Shoichiro, et al.
Publicado: (2018)

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
por: Hattori, Masaya, et al.
Publicado: (2017)

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
por: Ueno, Takayuki, et al.
Publicado: (2019)

Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)
por: Ahn, Sung Gwe, et al.
Publicado: (2021)

Capecitabine for primary breast cancer
por: Toi, Masakazu, et al.
Publicado: (2017)

Male Breast Cancer Originating in an Accessory Mammary Gland in the Axilla: A Case Report
por: Yamamura, Jun, et al.
Publicado: (2012)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple-negative breast cancer: A single institute retrospective study
por: Fujisawa, Fumie, et al.
Publicado: (2021)

Exotic clustering and halo states in $^{12,14}Be$
por: Orr, N A, et al.
Publicado: (1999)

Exotic molecular and halo states in ${12,14}Be$
por: Freer, M, et al.
Publicado: (1998)

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
por: Das, Prajnan, et al.
Publicado: (2006)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
por: Si, W., et al.
Publicado: (2013)

Concomitant (177)Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
por: Yadav, Madhav Prasad, et al.
Publicado: (2019)

Spontaneous coronary artery dissection during cisplatin and capecitabine therapy
por: Somov, Pavel, et al.
Publicado: (2019)

Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
por: Rhee, Jiyoung, et al.
Publicado: (2019)

Surgical therapy for pulmonary metastasis of breast cancer
por: Soh, Junichi, et al.
Publicado: (2020)

Primary Chest Wall Abscess Mimicking a Breast Tumor That Occurred after Blunt Chest Trauma: A Case Report
por: Yamaoka, Yusuke, et al.
Publicado: (2014)

$\beta$-delayed neutron emission from $^{12,14}$Be
por: Bergmann, U C, et al.
Publicado: (1999)

Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma
por: SAIF, MUHAMMAD WASIF, et al.
Publicado: (2014)

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
por: LIANG, XU, et al.
Publicado: (2015)

Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study
por: Li, Yi-Hui, et al.
Publicado: (2018)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer
por: Kawakami, Kazuyoshi, et al.
Publicado: (2017)

1214. Clinical characteristics of patients with adrenal insufficiency presenting fever
por: Jang, wooyoung, et al.
Publicado: (2020)

Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
por: Sato, Nobuaki, et al.
Publicado: (2018)

Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant
por: Gagliani, Nicola, et al.
Publicado: (2010)

Cognitive Training to Enhance Aphasia Therapy (Co-TrEAT): A Feasibility Study
por: Simic, Tijana, et al.
Publicado: (2022)

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
por: Cen, Putao, et al.
Publicado: (2008)

Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastases
por: Barai, Sukanta, et al.
Publicado: (2015)

Serial renography for evaluation of the impact of capecitabine therapy on renal function: A case report
por: Ren, Jiazhong, et al.
Publicado: (2017)

Loss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review
por: Zhao, Jian, et al.
Publicado: (2020)

Significant clinical response of advanced colorectal cancer to combination therapy involving capecitabine and adoptive cell transfer therapy: a case report
por: Li, Shuchun, et al.
Publicado: (2019)

A mathematical theory of the transcription repression (TR) therapy of cancer – whether and how it may work
por: Chen, Yuxin, et al.
Publicado: (2017)

XeNA: Capecitabine Plus Docetaxel, With or Without Trastuzumab, as Preoperative Therapy for Early Breast Cancer
por: Glück, Stefan, et al.
Publicado: (2008)

Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer
por: Santini, Daniele, et al.
Publicado: (2006)

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
por: Hsu, C-H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_d7u9v8uma2jhdeukfnce8og7i6